Older adults who have had cancer had a high risk of experiencing symptoms of depression during the early months of the COVID-19 pandemic according to a new study published in Cancer Management and Research.
The study was focused on a sample of 2486 adults aged 50 and older with a history of cancer who participated in the Canadian Longitudinal Study on Aging. Among the 1765 individuals from the study who had a history of cancer but no lifetime history of depression, researchers found that 1 in 8 experienced depression for the first time during the early stages of the pandemic.
Meghan Bird, first author, research assistant at the Factor-Inwentash Faculty of Social work at the University of Toronto Related StoriesWhen the researchers focused on the 786 individuals who had previously experienced depression, they found that approximately one-half of these individuals experienced a recurrence or persistence of depression during the COVID-19 pandemic.
Experiencing family conflict during the pandemic was associated with an approximate four-fold risk of both new and recurrent depression among older adults with a history of cancer. This finding is in keeping with research that has identified interpersonal conflict as a risk factor for depression among older adults. Other research indicates extended periods of lockdown and quarantine increase familial conflict.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
High levels of depression found among Canadian older adults with cancer during the COVID-19 pandemicOlder adults who have had cancer had a high risk of experiencing symptoms of depression during the early months of the COVID-19 pandemic according to a study published in Cancer Management and Research.
Read more »
Study identifies potential target for reversing drug resistance in ovarian cancerFor the 314,000 people diagnosed with ovarian cancer each year, hope often comes in the form of platinum-based drugs such as cisplatin.
Read more »